Thank we ensure began to volume strong the unit execute everyone, in double-digit and to us. and us growth sales net identified of this to optimism Jody returning we've continuation thank to and multi-part over opportunities the At long you sustainable for what joining year, Yes. implementing the term. for good strategy last We a about first gives and half growth and begun the future. of that quarter net an XXXX for improve presented afternoon you, sales
changes with mediocre now based hurt impacted we as industry, in necessary difficult, current the revenue on we reporting the but companies the seeing were are especially were pharma and these profile. indeed are which also reimbursement decisions the macroenvironment Now results, they
the the paid past per our effected the we quarters rebates recall, in certainly significantly net was geographical quarter than to best negatively the quarter. in and and sales first in first by also higher our And may beginning financial you net quarter. product provided impacted for reduced this unit revenue return the first at we locations realigned the second salesforce and the As
I number certainly Now address rebates, the about we to we the sell, of in while are net impact give higher units driving returning also action us the growth growth which as XXXX. of double-digit then to in optimism said, taking
Before I beginning product macroeconomic are deductible pharmaceutical our net rebate reset portion to new industry. discuss seasonal dynamic cover anticipate negative review out-of-pocket actions, at year those unit the I want of and insurance patients’ per in health the the effect We a the pricing greater as each briefly and revenue cost. of
Reduction recall our the of year if year. $X.X If had year-to-date from XXXX net more to pricing able our prior to this this XXXX have been plans per an by years. XX% sales unit end And year-end XXXX even significantly XXXX experiencing to we million. greater our our net reported was about pricing, increased to that been would differently, than reset, maintain effect impact you pronounced in as versus are revenue product these we gross healthcare of
Now, in NovaBay alone again, market not is dynamic. this
product reported increases. price Some net despite instances declines manufacturers large revenue several product in pharmaceutical in unit even in XXXX, per
& XXXX, discounts. net revenue average fee across in per after revenues even product For decrease more decline X.X% billion paying net rebates experienced their increase and $XX per X.X% than X.X% they reported portfolio. Johnson no of product by instance, the in in price an Johnson the took though unit And
net pricing of in X% more declines, investors year in product pricing on Johnson Johnson's pharmaceutical certainly are this companies & XXXX. coming decline and to prediction unit of warning Some up per –
retail on a pharmacy having sold increase we the as unit their discount our and rebates net a number a even higher the formidable through So impact channel. sales
second improvement mind, and which some salesforce sales that to in As the commercial we've expect impact health seasonality experienced quarter, expand up brings deductible. progresses to revenues their more late our in now net past, per satisfy plans unit in year representatives XX With patients as products we the in upgraded as the hiring did the match our realignment, seven organization new reps. by we
new years have covered of and All between health territories that been have experience, XX claim good and identified have ophthalmic coverage. representatives new these and product. trained pharmaceutical direct in promoting deployed sales be all as and will under XX then sales experience of have have we These reps
We calls good is additional on keeping based which profitable growth on their expect in plan prescribers sales reps high higher focus where with year reimbursement. based end targeting to This this by in salesforce hiring expand coverage. experience the Avenova on we of on health regions, primarily further formula, same sales before is the more
the Our benefits and the to patients patients their product. Avenova research has care that eye shown have who are understand specialist, embrace to brings the covered by tend of insurance more who
commercial are We of benefits through our We the includes our our certainly selecting in oversight better have better with the system focused Avenova prescribers communication proper job structure. of dry of they more their educating operations delivering. are training organizational a reps treatments to doing messaging the in patients. managing eye organization now of on This just for also to greater flatten sales
we also reporting new audience. to coverage Avenova actions with eye insurance other our unit. Most in product the plan forums as well or such secure our revenue Avenova, with objective are taken care progress the eye an of discuss as improving to net actions to where for we importantly, events health per enhanced broader and specialists benefits even have important can care reach We messages of
completing a plans Avenova background as of activities identifying support primary the our prospects We and including, preliminary the top this have support and number health initiative of documentation to care completed coverage.
top of the of to in health now XXXX. meetings select held care the are We and now plans be with process between arranging end
dry and eye types equates products represents have to we consumers that of market this promoted two coverage this by other of favorable heavily type about premise powerful efficiency of dry eye. are of So eye a Remember care Avenova. companies address the XX% for the support to decision the
leads eye, and of Meibomian earlier on Avenova Avenova which bacteria which On bacterial market. XX% the Dysfunction reduced mentioned to other hand, ocular validates about transitional represents skin the rise is resistance. anti-biotic I dry Gland addresses are antibiotics the certainly, dry cause that use eye. to give underlying surfaces for of it Avenova bacterial not Unlike chronic safe the because does Blepharitis,
the cold organizations dry about eye two better such As challenge after managed call, as the go we the we we mentioned, market were large with was last of the and reimbursement the we’re unfamiliar several very in eye. the these quarter’s dry There types organization formulas. face care educating of and Avenova, benefit
recognized direct have a sales generation. we additionally channel Now net volume viable in there in-office provides opportunity for
by refocusing our We and seeking are now going expanded acquisition who our separate to business over to we now opportunity one through an we efforts bag their team. result. financial to and the approaching co-promotion. financially that are maintain leverage and finally, via Jack like adding sustainable salesforce are inside I'd this channel to as And McGovern, turn to our or product is Jack? review And the call sales
